Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model (Q24629826)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model |
scientific article |
Statements
Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model (English)
Frederick R Appelbaum
John M Pagel
Aimee L Kenoyer
Donald K Hamlin
D Scott Wilbur
Darrell R Fisher
Steven I Park
Shani Frayo
Amanda Axtman
Nural Orgun
Johnnie Orozco
Jaideep Shenoi
Yukang Lin
Damian J Green
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference